Insights

Federated AI Advantage Apheris enables secure, local data processing and federated analytics for pharma, presenting a strong upsell opportunity to expand within pharma organizations seeking to keep IP sovereignty while enabling collaborative model improvements.

End-to-End Platform Recent GA of Compute Gateway 3.0 and end-to-end federated analytics suggest a compelling cross-sell to customers needing integrated tooling for data unlocking, collaboration, and scalable ML workflows across on-prem and cloud environments.

Drug Discovery Focus Target pharma companies concerned with data silos and regulatory/compliance pressures; Apheris’ platform addresses secure model training on proprietary datasets, positioning for deeper engagement with R&D, biotech startups, and CROs.

Strong Funding Signal Recent Series A funding and steady seed investments indicate investor confidence and growth trajectory, which can be leveraged to approach enterprise buyers with joint value propositions and roadmaps.

Platform Ecosystem Tech stack and data collaboration capabilities align with enterprises prioritizing data governance and interoperability; there is potential to partner with data providers, clinical trial firms, and cloud ecosystems to expand deployment footprints.

Apheris Tech Stack

Apheris uses 8 technology products and services including Amplitude, Google Cloud CDN, Microsoft Excel, and more. Explore Apheris's tech stack below.

  • Amplitude
    Analytics
  • Google Cloud CDN
    Content Delivery Network
  • Microsoft Excel
    Editors
  • Playwright
    Frameworks And Libraries
  • OpenCV
    Javascript Libraries
  • Microsoft Azure Machine Learning
    Machine Learning
  • Priority Hints
    Performance
  • Adobe Creative Suite
    Visualisation Software

Media & News

Apheris's Email Address Formats

Apheris uses at least 1 format(s):
Apheris Email FormatsExamplePercentage
F.Last@apheris.comJ.Doe@apheris.com
79%
First.Last@apheris.comJohn.Doe@apheris.com
14%
First@apheris.comJohn@apheris.com
3%
Last_First@apheris.comDoe_John@apheris.com
4%

Frequently Asked Questions

What is Apheris's official website and social media links?

Minus sign iconPlus sign icon
Apheris's official website is apheris.com and has social profiles on LinkedIn.

What is Apheris's NAICS code?

Minus sign iconPlus sign icon
Apheris's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Apheris have currently?

Minus sign iconPlus sign icon
As of July 2026, Apheris has approximately 52 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Ceo & Co-Founder: R. R.Cto & Co-Founder: M. H.Director Of Ai Solution Architecture: J. F.. Explore Apheris's employee directory with LeadIQ.

What industry does Apheris belong to?

Minus sign iconPlus sign icon
Apheris operates in the Computer and Network Security industry.

What technology does Apheris use?

Minus sign iconPlus sign icon
Apheris's tech stack includes AmplitudeGoogle Cloud CDNMicrosoft ExcelPlaywrightOpenCVMicrosoft Azure Machine LearningPriority HintsAdobe Creative Suite.

What is Apheris's email format?

Minus sign iconPlus sign icon
Apheris's email format typically follows the pattern of F.Last@apheris.com. Find more Apheris email formats with LeadIQ.

How much funding has Apheris raised to date?

Minus sign iconPlus sign icon
As of July 2026, Apheris has raised $32M in funding. The last funding round occurred on Jan 02, 2025.

When was Apheris founded?

Minus sign iconPlus sign icon
Apheris was founded in 2019.
Apheris logo

Apheris

Computer and Network SecurityBerlin, Germany51-200 Employees

Apheris is a Berlin-based company operating in the computer and network security sector, focused on delivering enterprise-grade AI applications for drug discovery that can run and be customized securely within a customer’s own IT environment. By keeping data local, its solutions give pharma organizations sovereignty over intellectual property and sensitive assets while enabling local deployments that underpin federated data networks for collaborative model training and benchmarking on proprietary datasets. The approach is aimed at enabling more robust and generalizable AI models for drug discovery through secure, in-house processing and controlled collaboration across datasets. The company positions itself in the security and data governance space for life sciences, offering an end-to-end platform that supports federated analytics and machine learning in regulated environments. Based in Berlin, Apheris has grown to serve enterprise customers with a focus on pharmaceutical companies seeking to unlock insights from sensitive data without transferring it off premises.

Section iconCompany Overview

NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $32M

    Apheris has raised a total of $32M of funding over 5 rounds. Their latest funding round was raised on Jan 02, 2025as a series_a.

  • $1M$10M

    Apheris's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $32M

    Apheris has raised a total of $32M of funding over 5 rounds. Their latest funding round was raised on Jan 02, 2025as a series_a.

  • $1M$10M

    Apheris's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.